ROTONDI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 6.238
AS - Asia 4.936
EU - Europa 3.707
SA - Sud America 779
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 15.756
Nazione #
US - Stati Uniti d'America 6.109
CN - Cina 2.460
SG - Singapore 1.174
IE - Irlanda 1.011
HK - Hong Kong 688
BR - Brasile 644
RU - Federazione Russa 508
UA - Ucraina 447
DE - Germania 398
FI - Finlandia 379
IT - Italia 335
VN - Vietnam 240
GB - Regno Unito 205
SE - Svezia 164
JP - Giappone 97
FR - Francia 90
CA - Canada 58
AR - Argentina 55
IN - India 50
MX - Messico 47
BD - Bangladesh 44
NL - Olanda 38
PL - Polonia 35
IQ - Iraq 32
EC - Ecuador 27
ZA - Sudafrica 24
TR - Turchia 22
ID - Indonesia 21
BE - Belgio 19
AT - Austria 18
ES - Italia 17
PK - Pakistan 15
MA - Marocco 13
VE - Venezuela 12
CL - Cile 11
JO - Giordania 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
KE - Kenya 9
UY - Uruguay 9
KR - Corea 8
LT - Lituania 7
DZ - Algeria 6
TN - Tunisia 6
AZ - Azerbaigian 5
EU - Europa 5
MC - Monaco 5
PY - Paraguay 5
BB - Barbados 4
CH - Svizzera 4
CR - Costa Rica 4
ET - Etiopia 4
GA - Gabon 4
IL - Israele 4
LB - Libano 4
MM - Myanmar 4
NP - Nepal 4
BO - Bolivia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IR - Iran 3
KG - Kirghizistan 3
LV - Lettonia 3
MU - Mauritius 3
NI - Nicaragua 3
PA - Panama 3
PE - Perù 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
QA - Qatar 2
RO - Romania 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IS - Islanda 1
Totale 15.740
Città #
Dublin 1.011
Chandler 963
Dallas 750
Hong Kong 684
Jacksonville 582
Nanjing 528
Singapore 440
Ashburn 434
Beijing 390
Boardman 312
Princeton 207
Nanchang 204
Lawrence 198
Wilmington 170
Hebei 166
Los Angeles 165
Shenyang 149
Changsha 145
Medford 138
Jiaxing 116
Buffalo 105
Moscow 105
Helsinki 98
Ho Chi Minh City 96
Tokyo 95
New York 91
Milan 79
Tianjin 79
Redondo Beach 77
Shanghai 75
Ann Arbor 73
Hangzhou 72
Munich 71
São Paulo 64
The Dalles 46
Woodbridge 45
Hanoi 43
Santa Clara 41
Piscataway 35
Verona 35
Falls Church 33
Warsaw 32
Falkenstein 30
Chicago 26
San Genesio Ed Uniti 26
Mexico City 25
Rome 25
Columbus 24
Norwalk 24
Pavia 24
Seattle 24
Guangzhou 23
Stockholm 22
Brooklyn 21
Belo Horizonte 20
San Francisco 20
Boston 19
Brussels 19
Montreal 19
Nuremberg 19
Toronto 19
Turku 18
Chennai 17
Dhaka 17
Curitiba 16
Rio de Janeiro 16
Zhengzhou 16
Ankara 15
Fairfield 15
Johannesburg 15
Kunming 15
London 15
Orem 15
Washington 15
Auburn Hills 14
Haiphong 14
Phoenix 14
Atlanta 13
Baghdad 13
Poplar 12
Xi'an 12
Amman 11
Amsterdam 11
Denver 11
Frankfurt am Main 11
Houston 11
Manchester 11
Florence 10
Jinan 10
Naples 10
Ningbo 10
Tappahannock 10
Vienna 10
Des Moines 8
Guayaquil 8
Shijiazhuang 8
Taizhou 8
Tashkent 8
Bologna 7
Buenos Aires 7
Totale 10.148
Nome #
The in vitro effects of Voghera sweet pepper on thyroid cancer cells: modulation of oxidative stress and pro-tumorigenic genes 315
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 140
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: The hidden role of thyroid autoimmunity 131
A Unique Patient Presenting with Concomitant Klinefelter Syndrome, Alport Syndrome and Craniopharyngioma. 120
Disabling portosystemic encephalopathy in a non-cirrhotic patient: Successful endovascular treatment of a giant inferior mesenteric-caval shunt via the left internal iliac vein 119
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. 118
A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. 114
An improved polymerase chain reaction (PCR) protocol for unambigous detection of growth hormone gene deletions. 113
Effect of Interferon-γ on the Basal and the TNF α-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement or the BRAF V600e Mutation 111
TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer 111
An unusual therapeutic approach to a large thyroid nodule 102
Body weight changes in a large cohort of patients subjected to thyroidectomy for a wide spectrum of thyroid diseases 101
Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard 100
Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. 99
Prevalence of Double Pituitary Adenomas in a Surgical Series: Clinical, Histological and Genetic Features. 99
THYREOTROPIN LEVELS IN DIABETIC PATIENTS ON METFORMIN TREATMENT. 99
Compared with classic Hashimoto’s thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of l-thyroxine to correct hypothyroidism 99
A unique presentation of Graves' disease in a pregnant woman with severe hypothyroidism 97
CB1 receptor antagonism/inverse agonism increases motor system excitability in humans. 97
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate? 96
Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. 95
Extraocular muscle antibodies positivity as the only serum marker of euthyroid Graves' ophthalmopathy following subacute thyroiditis: case report. 94
Shear wave elastography in the diagnosis of thyroid nodules: feasibility in the case of coexistent chronic autoimmune Hashimoto's thyroiditis 94
Expanding the therapeutic spectrum of metformin: From diabetes to cancer 94
A male patient with acromegaly and breast cancer: Treating acromegaly to control tumor progression 94
Basal and longitudinal changes in serum levels of TSH in morbid obese patients experiencing failure or success of dietary treatment 93
Etiopathogenesis of Basedow's disease. Trends and current aspects 92
Post partum and non-post partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs 91
Early spermatogenesis changes in traumatic complete spinal cord-injured adult patients 91
Adverse effects of in vitro GenX exposure on rat thyroid cell viability, DNA integrity and thyroid-related genes expression 90
Graves' disease. 89
Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes. 88
The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration 88
Autoimmune thyroid diseases in patients treated with alemtuzumab for multiple sclerosis: An example of selective anti-TSH-receptor immune response 88
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 88
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 87
Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage 87
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells. 86
Management of subclinical hypothyroidism in pregnancy: a comment from the Italian Society of Endocrinology and the Italian Thyroid Association to the 2017 American Thyroid Association Guidelines: "The Italian Way" 86
-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. 84
DIAGNOSIS OF ENDOCRINE DISEASE: IgG4-related thyroid autoimmune disease 83
Nivolumab induced thyroid dysfunction: Unusual clinical presentation and challenging diagnosis 83
Intraepidermal nerve fiber density reduction as a marker of preclinical asymptomatic small-fiber sensory neuropathy in hypothyroid patients. 82
Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. 81
Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. 81
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. 80
Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism. 80
Toxic Diffuse Goiter (Basedow-Graves' Disease) 80
Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. 80
Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community 80
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells 80
Diabetes insipidus and increased serum levels of leptin and lactate-dehydrogenase (LDH) in an adolescent boy with a primary intracranial germinoma. Case report and an endocrinological revaluation of literature. 79
Pretransplant Positivity for Circulating Thyroid Antibodies and Graft Survival in Patients Undergoing Kidney Transplant. 79
Reverse phenotyping after whole-Exome sequencing in steroid-resistant nephrotic syndrome 79
A first-trimester serum TSH in the 4-10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women 78
Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. 78
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 77
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. 77
Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. 77
Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. 77
Ultrasound of benign thyroid nodules: a 120 months follow-up study 77
Repeated laser thermal ablation of a large functioning thyroid nodule restores euthyroidism and ameliorates constrictive symptoms. 76
Metodo diagnostico per la previsione di rigetto di organo trapiantato 76
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study. 75
Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis. 75
CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice. 75
2017 ATA guidelines on the management of thyroid dysfunctions in pregnancy: what do OB/GYNs need to know? 75
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. 74
Metformin reverts the secretion of CXCL8 induced by TNF-α in primary cultures of human thyroid cells: An additional indirect anti-tumor effect of the drug 74
The Amh as a predictor of ovarian reserve and the role of thyroid autoimmunity in the protocols of assisted reproduction techniques 74
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. 73
Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. 73
Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease. 73
Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait 73
COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator? 73
Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy 73
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. 72
Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk. 72
Seronegative autoimmune diseases: A challenging diagnosis 71
Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis. 71
Studying plasticity of sensory function: insight from pregnancy. 71
Migration flows affect women’s dietary iodine intake and jeopardize their iodine sufficiency: a pilot study 71
The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes 71
Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH 71
High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. 70
Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. 70
Uso de antagonistas y/o agonistas inversos de los receptores CB1 para la preparacion de medicamentos que incrementen la excitabilidad de las motoneuronas 70
Thyroid function in children and adolescents with Hashimoto’s thyroiditis afterL-thyroxine discontinuation 70
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis 70
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. 69
Prenatal measurement of testicular diameter by ultrasonography: development of fetal male gender and evaluation of testicular descent. 69
The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease. 69
Interferon-B but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: A clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs 69
Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association 69
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension. 69
Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion 69
Unusual case of cervical pregnancy after curettage for a presumptive diagnosis of intrauterine blighted ovum. 68
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. 68
Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease. 68
Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle. 68
Totale 8.635
Categoria #
all - tutte 78.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021635 0 0 0 0 0 100 95 156 33 127 100 24
2021/2022796 18 8 3 26 24 27 15 57 50 7 140 421
2022/20232.750 288 148 68 238 260 266 0 152 1.208 16 74 32
2023/20241.034 145 178 37 74 86 224 26 58 4 29 58 115
2024/20253.143 51 234 52 143 87 196 139 236 788 143 270 804
2025/20264.378 491 529 1.118 986 919 335 0 0 0 0 0 0
Totale 16.141